Polycystic Ovary Syndrome
Also known as: PCOS, polycystic ovarian syndrome, Stein-Leventhal syndrome
10–15%
Of Black reproductive-age women; often underdiagnosed
Overview
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting people with ovaries, estimated to affect 8–13 percent of reproductive-age women worldwide. It is characterized by a combination of ovulatory dysfunction, androgen excess, and polycystic ovarian morphology on ultrasound. Diagnosis requires meeting at least two of three Rotterdam criteria. PCOS is strongly associated with insulin resistance, which drives its link to type 2 diabetes, cardiovascular risk, and metabolic syndrome. It is also a leading cause of anovulatory infertility. The name is somewhat misleading: polycystic ovaries are not required for diagnosis, and the 'cysts' are actually arrested follicles.
How Polycystic Ovary Syndrome affects Black patients
PCOS affects approximately 10–15 percent of Black reproductive-age women, but is significantly underdiagnosed in this population. Studies document an average diagnostic delay of 2 or more years compared to white women. Several factors contribute: providers may attribute hirsutism differently in Black women, ovarian ultrasound findings are interpreted using European-derived normative data, and the overlap between PCOS symptoms and other common conditions (thyroid disease, insulin resistance) leads to diagnostic confusion. Lean PCOS — PCOS in women with normal BMI — is clinically important in Black women: BMI is a poor proxy for insulin resistance in this population, and normal-weight Black women with PCOS may still carry significant metabolic risk that is missed if providers only screen heavier patients. Black women with PCOS face elevated risk of type 2 diabetes, hypertension, and endometrial cancer from chronic anovulation.
Symptoms
- Irregular, infrequent, or absent menstrual periods
- Signs of androgen excess: unwanted facial or body hair growth (hirsutism), acne, and thinning scalp hair
- Difficulty becoming pregnant (anovulatory infertility)
- Weight gain, particularly around the abdomen
- Darkened skin patches in folds (acanthosis nigricans) — sign of insulin resistance
- Mood disturbances: depression and anxiety at higher rates than general population
- Pelvic pain (less common)
When to see a doctor
See a gynecologist or endocrinologist if you have irregular periods, signs of excess androgen, or difficulty conceiving. Ask to be evaluated with both blood tests (LH, FSH, total and free testosterone, DHEAS, prolactin, thyroid function, fasting glucose, insulin) and pelvic ultrasound — diagnosis requires a combination of these, not any single result alone.
If you have been told your symptoms are 'just irregular periods' without a full endocrine workup and imaging, requesting a comprehensive evaluation or a second opinion is appropriate.
Screening
No population-wide PCOS screening is recommended. All women with irregular menstrual cycles, hirsutism, or difficulty conceiving should be evaluated. Rotterdam criteria (2003) require at least two of: (1) oligo/anovulation, (2) clinical or biochemical signs of hyperandrogenism, (3) polycystic ovarian morphology on ultrasound. Because PCOS markedly increases T2D risk, a 75-gram oral glucose tolerance test (OGTT) is preferred over A1C alone for diabetes screening in PCOS patients.
Treatment overview
Combined oral contraceptive pills (COCPs) are first-line for menstrual regulation and androgen suppression in women not seeking pregnancy. Metformin improves insulin sensitivity, restores ovulatory function, and reduces long-term metabolic risk — it is particularly appropriate for women with glucose intolerance or metabolic syndrome. For women seeking fertility, letrozole (an aromatase inhibitor) is now preferred over clomiphene as first-line ovulation induction per ADA and ACOG guidance. Spironolactone reduces hirsutism. GLP-1 receptor agonists (semaglutide) address obesity and metabolic features in PCOS. Endometrial protection through regular progestin cycling is essential to prevent endometrial hyperplasia in chronically anovulatory women not on hormonal contraception.
Questions to ask your doctor
Bring this list to your next appointment.
- Was I evaluated with a pelvic ultrasound, a full hormone panel, and a glucose tolerance test?
- Do I have lean PCOS (normal BMI but insulin resistance)? How are you checking for that?
- What are my fertility options if I want to conceive — letrozole, clomiphene, or IVF?
- Should I be on metformin given my insulin resistance and diabetes risk?
- Do I need endometrial protection given my irregular cycles?
- What is my cardiovascular risk, and how should we monitor it?
- How frequently should you check my blood sugar?
Find a OB-GYN
Search our directory of verified Black health providers who specialize in ob-gyn.
Browse OB-GYN providersMedical disclaimer
This content is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. If you are experiencing a medical emergency, call 911 or your local emergency number immediately.